Land, Michelle A.
Chapman, Holly L.
Davis-Reyes, Brionna D.
Felsing, Daniel E.
Allen, John A.
Moeller, F. Gerard
Elferink, Lisa A.
Cunningham, Kathryn A.
Anastasio, Noelle C.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (DA033935, DA033935, DA033935)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
Article History
Received: 28 January 2019
Accepted: 21 October 2019
First Online: 13 November 2019
Competing interests
: F.G.M. has current research funding from Indivior Pharmaceuticals and Nektar therapeutics for research unrelated to this study. All other authors declare no competing interests.